Skip to menu Skip to content Skip to footer

2008

Conference Publication

Chronic kidney disease management: a multidisciplinary clinic model

Frazier, J., Blizzard, S., Douglas, B., Oliver, V., Johnson, D., Hawley, C., Campbell, S., Mudge, D. and Isbel, N. (2008). Chronic kidney disease management: a multidisciplinary clinic model. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Richmond, VIC, Australia: Wiley-Blackwell.

Chronic kidney disease management: a multidisciplinary clinic model

2008

Conference Publication

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

Gobe, G. C., Johnson, D. W., Li, J., Pat, B. K., Percy, C. J. and Rajandram, R. (2008). Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 5-8 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Immunotherapy and radiation increase apoptosis in renal cell carcinoma: Identification of potential diagnostic markers

2008

Conference Publication

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Carlton, Australia: Blackwell. doi: 10.1111/j.1440-1797.2008.001013.x

Human recombinant erythropoietin vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

Percy, C., Brown, L., Johnson, D. W., Power, D. and Gobe, G. C. (2008). Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. OXFORD: BLACKWELL PUBLISHING.

Renal age-related chronic disease is associated with key cellular and molecular changes that are modulated by hypertension and obesity

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G., Bennett, N., Patel, J., Yamada, M., Colditz, P. and Johnson, D. (2008). Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. Hoboken, NJ, United States: Wiley-Blackwell.

Recombinant human erythropoietin increases vascular expression of Nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2008

Conference Publication

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

Gobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology.

Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses

2008

Conference Publication

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

Brooks, E. K., Johnson, D. W., Staatz, Christine E., Taylor, P. J. and Tett, Susan E. (2008). Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation. Australian Health and Medical Research Congress (AHMRC) 2008, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Early calcineurin inhibitor and mycophenolate mofetil exposure and acute rejection and drug toxicity after renal transplantation

2008

Conference Publication

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

Gobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x

Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease

2008

Conference Publication

Implementation of the routine reporting of eGFR in Australia and New Zealand

Jones, Graham R. D., Mathew, Timothy, Johnson, David and Peake, Michael (2008). Implementation of the routine reporting of eGFR in Australia and New Zealand. 11th Bergmeyer Conference, Eibsee, 2008. Taylor & Francis. doi: 10.1080/00365510802144953

Implementation of the routine reporting of eGFR in Australia and New Zealand

2008

Conference Publication

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

Gobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x

Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury

2007

Conference Publication

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

Mollee, Peter, Hourigan, Matthew, Johnson, David, Jones, Mark, Isbel, Nikki, Hawley, Carmel, Marlton, Paula, Gandhi, Maher, Campbell, Scott and Gill, Devinder (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta, GA USA, 8-11 December 2007. Washington, DC USA: American Society of Hematology.

Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients

2007

Conference Publication

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

Clark, C. J., Johnson, D., Hawley, C., May, K., Campbell, S., Isbel, N., Mudge, D. and Burke, J. (2007). The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD). 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

The impact of late referral to a nephrologist on access infections in peritoneal dialysis (PD) and haemodialysis (HD)

2007

Conference Publication

Molecular and cellular changes associated with age-related chronic kidney disease

Percy, C., Brown, L., Power, D., Johnson, D. W. and Gobe, G. C. (2007). Molecular and cellular changes associated with age-related chronic kidney disease. International Society of Nephrology's World Congress of Nephrology 2007, Rio de Janeiro, Brazil, 21-25 April 2007.

Molecular and cellular changes associated with age-related chronic kidney disease

2007

Conference Publication

Erythropoietin: Novel applications beyond anaemia treatment

Vesey, D. A., Gobe, G. C. and Johnson, D. W. (2007). Erythropoietin: Novel applications beyond anaemia treatment. 2nd International Conference of Naresuan University, Phitsanulok, Thailand, 27-28 July, 2007.

Erythropoietin: Novel applications beyond anaemia treatment

2007

Conference Publication

What is the optimal fat mass in peritoneal dialysis patients?

Johnson, David W. (2007). What is the optimal fat mass in peritoneal dialysis patients?. 11th Congress of the International Society for Peritoneal Dialysis, Hong Kong, 25 - 29 August, 2006. Milton, Ontario: Multimed.

What is the optimal fat mass in peritoneal dialysis patients?

2007

Conference Publication

Live donor characteristics over the last 15 years

Kaisar, M. O., Campbell, S., Hawley, C., Johnson, D., Mudge, D., Griffin, A., Wall, D., Preston, J., Nicol, D. and Isbel, N. (2007). Live donor characteristics over the last 15 years. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Live donor characteristics over the last 15 years

2007

Conference Publication

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

Rajandram, R., Pat, B. K., Li, J., Percy, C. J., Johnson, D. W. and Gobe, G. C. (2007). Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers. 46th ASMR National Scientific Conference, Katoomba, N.S.W., Australia, 11-13 November 2007.

Immunotherapy and radiation on the apoptosis-associated gene profile of renal cell carcinoma: Identification of potential diagnostic markers

2007

Conference Publication

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

Kaisar, M. O., Hawley, C. M., Mudge, D. W., Campbell, S. B., Johnson, D. W. and Isbel, N. M. (2007). Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient. 43rd Australian and New Zealand Society of Nephrology Annual Scientific Meeting, Gold Coast, Australia, 8–12 September 2007. Hoboken, NJ United States: Wiley-Blackwell.

Collapsing glomerulopathy secondary to human parvovirus b19 in a kidney-pancreas transplant recipient

2007

Conference Publication

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients

Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. American Transplant Congress 2007, USA, 5-9 May 2007. UK: Wiley-Blackwell Publising Ltd.. doi: 10.1111/j.1600-6143.2007.01811.x

Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients